Nima Shariati
Senior Biostatistician & Data Science Team Lead Roche
Nima Shariati, PhD, is a Data Science Team Lead and Project Lead Statistician at Hoffmann-La Roche in Switzerland, with over a decade of experience in clinical drug development within the pharmaceutical industry, primarily in the neurodegeneration therapeutic area, particularly Parkinson’s and Alzheimer’s clinical development. Nima is a member of the Estimand Subject Matter Expert (SME) network within Roche, where he has been actively instructing and advocating for the use of the estimand framework in clinical trial design, as well as the European Quantitative Decision Making Special Interest Group (E-SIG) within PSI (Statisticians in the Pharmaceutical Industry), where he provides innovative applications of adaptive design in drug development and quantitative decision making to enhance the performance of clinical trials design and optimize the portfolio. Prior to Roche, Nima worked as a senior statistician at AstraZeneca and obtained his PhD from the University of Lund in Sweden.
Seminars
- Designing smarter clinical trials for slowly progressing Parkinson’s populations, reducing operational hurdles while improving feasibility and signal detection
- Optimizing endpoint selection with robust statistical frameworks that reflect disease biology and patient reality, supporting regulatory and clinical confidence
- Enabling sponsors to run faster, leaner, and more conclusive studies that unlock disease-modifying therapies for patients sooner
VIRTUAL
